![]() |
Market Research Report
Product code
1043174
Global Clinical Trial Management Systems Market |
Global Clinical Trial Management Systems Market |
Published: December 14, 2021
BCC Research
Content info: 96 Pages
Delivery time: 1-2 business days
|
The global market for clinical trial management systems should reach $1.6 billion by 2026 from $920.8 million in 2021 at a compound annual growth rate (CAGR) of 12.2% for the forecast period of 2021 to 2026.
The software segment of the global clinical trial management systems market is expected to grow from $682.3 million in 2021 to $1.2 billion in 2026 at a CAGR of 11.9% for the forecast period of 2021 to 2026.
The services segment of the global clinical trial management systems market is expected to grow from $238.5 million in 2021 to $444.3 million in 2026 at a CAGR of 13.2% for the forecast period of 2021 to 2026.
This report examines the current and forecasted market potential for clinical trial management systems. It offers a detailed analysis of the market background, technological advancement, competitive environment, drivers and restraints, and market growth trends. This report includes market projections through 2026, detailing the market share for clinical trial management systems based on the product, deployment and delivery mode.
The clinical trial management systems product market is segmented into software and services. The clinical trial management systems deployment market is segmented into enterprise-based CTMS and site-based CTMS. The clinical trial management systems delivery market is segmented into web-based, cloud-based and on-premises services.
The clinical trial management systems market has been geographically segmented into Europe, North America, the Asia-Pacific (APAC) region and the Rest of the World (RoW). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India and China are regional segments. For market estimates, data are provided for 2020 as the base year, and then forecast form 2021 through year-end 2026. Estimated values are based on clinical trial management systems companies' total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.